WTFG
BMY icon

Wells Trecaso Financial Group’s Bristol-Myers Squibb BMY Stock Holding History

Wells Trecaso Financial Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$852K Sell
18,889
-21,602
-53% -$1.01M 0.41% 46
2025
Q2 		$1.87M Sell
40,491
-1,624
-4% -$79.7K 0.58% 38
2025
Q1 		$2.57M Sell
42,115
-142
-0.3% -$8.28K 0.86% 31
2024
Q4 		$2.39M Sell
42,257
-1,730
-4% -$96.7K 0.78% 32
2024
Q3 		$2.28M Sell
43,987
-1,745
-4% -$81.9K 0.75% 32
2024
Q2 		$1.9M Sell
45,732
-1,915
-4% -$85.7K 0.66% 33
2024
Q1 		$2.58M Sell
47,647
-4,536
-9% -$231K 0.91% 29
2023
Q4 		$2.68M Sell
52,183
-9,675
-16% -$508K 1.08% 26
2023
Q3 		$3.59M Sell
61,858
-1,570
-2% -$96.2K 1.6% 24
2023
Q2 		$4.06M Sell
63,428
-1,762
-3% -$118K 1.75% 23
2023
Q1 		$4.52M Buy
65,190
+851
+1% +$60K 2.09% 21
2022
Q4 		$4.63M Buy
64,339
+696
+1% +$52.5K 2.31% 20
2022
Q3 		$4.52M Buy
63,643
+65
+0.1% +$4.71K 2.48% 19
2022
Q2 		$4.9M Sell
63,578
-375
-0.6% -$28.6K 2.54% 16
2022
Q1 		$4.67M Buy
63,953
+2,320
+4% +$156K 2.08% 22
2021
Q4 		$3.84M Buy
61,633
+1,844
+3% +$108K 1.67% 22
2021
Q3 		$3.54M Buy
59,789
+1,112
+2% +$73.2K 1.69% 24
2021
Q2 		$3.92M Buy
58,677
+3,035
+5% +$198K 1.89% 22
2021
Q1 		$3.51M Buy
55,642
+1,145
+2% +$71.2K 1.85% 23
2020
Q4 		$3.38M Buy
54,497
+3,303
+6% +$203K 1.88% 22
2020
Q3 		$3.09M Buy
51,194
+5,360
+12% +$323K 1.97% 19
2020
Q2 		$2.69M Buy
45,834
+3,927
+9% +$235K 1.86% 21
2020
Q1 		$2.34M Buy
41,907
+2,030
+5% +$124K 2.08% 17
2019
Q4 		$2.56M Buy
39,877
+500
+1% +$28.6K 1.85% 18
2019
Q3 		$2M Buy
39,377
+895
+2% +$42.1K 1.59% 20
2019
Q2 		$1.75M Sell
38,482
-1,060
-3% -$49.4K 1.43% 21
2019
Q1 		$1.89M Sell
39,542
-535
-1% -$26.6K 1.58% 20
2018
Q4 		$2.08M Buy
40,077
+342
+0.9% +$18.4K 1.99% 18
2018
Q3 		$2.47M Sell
39,735
-930
-2% -$55.2K 2.05% 17
2018
Q2 		$2.25M Sell
40,665
-1,945
-5% -$105K 2.11% 19
2018
Q1 		$2.69M Buy
42,610
+6,057
+17% +$390K 2.57% 15
2017
Q4 		$2.24M Buy
+36,553
New +$2.29M 2.19% 19

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Trecaso Financial Group's BMY Position: Q3 2025 in Review

Wells Trecaso Financial Group reduced its Bristol-Myers Squibb (BMY) stake by 53% in Q3 2025, selling an estimated $1.01M and leaving 18,889 shares worth $852K. The position accounts for 0.41% of the portfolio, ranked #46.

Wells Trecaso Financial Group first reported a position in BMY in Q4 2017 and has held it in 32 quarters since. The position peaked at $4.9M in Q2 2022. 2,268 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

  • Wells Trecaso Financial Group held 18,889 shares of Bristol-Myers Squibb worth $852K as of Q3 2025.
  • Wells Trecaso Financial Group sold 21,602 Bristol-Myers Squibb shares in Q3 2025, an estimated $1.01M.
  • Bristol-Myers Squibb made up 0.41% of Wells Trecaso Financial Group's portfolio in Q3 2025, its #46 holding.
  • Wells Trecaso Financial Group first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 32 quarters since.
  • Wells Trecaso Financial Group's Bristol-Myers Squibb position peaked at $4.9M in Q2 2022.
  • 2,268 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on Wells Trecaso Financial Group's 13F filing for Q3 2025, filed 5 Nov 2025.